Agomelatine (BioDeep_00000018234)
human metabolite blood metabolite Chemicals and Drugs
代谢物信息卡片
N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide
化学式: C15H17NO2 (243.12592220000002)
中文名称: 阿戈美拉汀
谱图信息:
最多检出来源 Homo sapiens(blood) 7.41%
Reviewed
Last reviewed on 2024-09-14.
Cite this Page
Agomelatine. BioDeep Database v3. PANOMIX ltd, a top metabolomics service provider from China.
https://query.biodeep.cn/s/agomelatine (retrieved
2024-11-05) (BioDeep RN: BioDeep_00000018234). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
分子结构信息
SMILES: CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC
InChI: InChI=1S/C15H17NO2/c1-11(17)16-9-8-13-5-3-4-12-6-7-14(18-2)10-15(12)13/h3-7,10H,8-9H2,1-2H3,(H,16,17)
描述信息
Agomelatine is structurally closely related to melatonin. Agomelatine is a potent agonist at melatonin receptors and an antagonist at serotonin-2C (5-HT2C) receptors, tested in an animal model of depression. Agomelatine was discovered and developed by the European pharmaceutical company Servier Laboratories Ltd. Servier continue to develop the drug and conduct phase III trials in the European Union. In 2005 Servier submitted Agomelatine to the European Medicines Agency (EMEA). On 27 July 2006 the Committee for Medical Products for Human Use (CHMP) of the EMEA recommended a refusal of the marketing authorisation of Valdoxan/Thymanax. The major concern was that efficacy had not been sufficiently shown. In 2006 Servier sold the rights to develop Agomelatine in the US to Novartis. The development for the US market was discontinued in October 2011. It is currently sold in Australia under the Valdoxan trade name.
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist
C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants
Agomelatine (S-20098) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively[1]. Agomelatine is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively[2].
同义名列表
数据库引用编号
11 个数据库交叉引用编号
- ChEBI: CHEBI:134990
- PubChem: 82148
- HMDB: HMDB0015636
- DrugBank: DB06594
- ChEMBL: CHEMBL10878
- Wikipedia: Agomelatine
- chemspider: 74141
- CAS: 138112-76-2
- PMhub: MS000004468
- RefMet: Agomelatine
- medchemexpress: HY-17038
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Tian-Ze Li, Jing Hu, Jin-Jin Sun, Xiao-Yan Huang, Chang-An Geng, Shu-Bai Liu, Xue-Mei Zhang, Ji-Jun Chen. Synthesis and biological evaluation of paeoveitol D derivatives as new melatonin receptor agonists with antidepressant activities.
RSC medicinal chemistry.
2022 Oct; 13(10):1212-1224. doi:
10.1039/d2md00156j. [PMID: 36325395] - Gulin Ozdamar Unal, Arif Demirdas, Mustafa Nazıroglu, Ishak Suat Ovey. Agomelatine attenuates calcium signaling and apoptosis via the inhibition of TRPV1 channel in the hippocampal neurons of rats with chronic mild stress depression model.
Behavioural brain research.
2022 09; 434(?):114033. doi:
10.1016/j.bbr.2022.114033. [PMID: 35914635] - Patricia Diez-Echave, Teresa Vezza, Francesca Algieri, Antonio Jesús Ruiz-Malagón, Laura Hidalgo-García, Federico García, Rocío Morón, Manuel Sánchez, Marta Toral, Miguel Romero, Juan Duarte, José Garrido-Mesa, María Elena Rodríguez-Cabezas, Alba Rodríguez-Nogales, Julio Gálvez. The melatonergic agonist agomelatine ameliorates high fat diet-induced obesity in mice through the modulation of the gut microbiome.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
2022 Sep; 153(?):113445. doi:
10.1016/j.biopha.2022.113445. [PMID: 36076560] - Maleeha Gul, Fawad Ali Shah, Najam-Us Sahar, Imran Malik, Fakhar Ud Din, Saeed Ahmad Khan, Waqar Aman, Ho-Ik Choi, Chang-Wan Lim, Ha-Yeon Noh, Jin-Su Noh, Alam Zeb, Jin-Ki Kim. Formulation optimization, in vitro and in vivo evaluation of agomelatine-loaded nanostructured lipid carriers for augmented antidepressant effects.
Colloids and surfaces. B, Biointerfaces.
2022 Aug; 216(?):112537. doi:
10.1016/j.colsurfb.2022.112537. [PMID: 35561634] - Sasivimon Promsan, Laongdao Thongnak, Nattavadee Pengrattanachot, Nichakorn Phengpol, Prempree Sutthasupha, Anusorn Lungkaphin. Agomelatine, a structural analog of melatonin, improves kidney dysfunction through regulating the AMPK/mTOR signaling pathway to promote autophagy in obese rats.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
2022 Jul; 165(?):113190. doi:
10.1016/j.fct.2022.113190. [PMID: 35640855] - Erika Cecon, Charlotte Izabelle, Sophie Le Poder, Fernando Real, Aiwei Zhu, Ly Tu, Maria Rosa Ghigna, Bernard Klonjkowski, Morgane Bomsel, Ralf Jockers, Julie Dam. Therapeutic potential of melatonin and melatonergic drugs on K18-hACE2 mice infected with SARS-CoV-2.
Journal of pineal research.
2022 Jan; 72(1):e12772. doi:
10.1111/jpi.12772. [PMID: 34586649] - Zihong Liang, Yanbo Jia, Lizhen Zhao, Runxiu Zhu, Xuemei He, Bagen Tong, Fan Yang, Lixia Hao, Pengfei Cui, Jun Yuan. Agomelatine might be more appropriate for elderly, depressed, type 2 diabetes mellitus patients than paroxetine/fluoxetine.
Aging.
2021 10; 13(19):22934-22946. doi:
10.18632/aging.203586. [PMID: 34610580] - Beata Łebkowska-Wieruszewska, Hubert Ziółkowski, Irene Sartini, Andrzej Lisowski, Cezary J Kowalski, Amnart Poapolathep, Mario Giorgi. Agomelatine: A novel melatonergic antidepressant. Method validation and first exploratory pharmacokinetic study in fasted and fed dogs.
Research in veterinary science.
2021 Oct; 139(?):140-144. doi:
10.1016/j.rvsc.2021.07.019. [PMID: 34303122] - Shakeeb Ahmed, Syed Mahmood, Mohd Danish Ansari, Azka Gull, Nitin Sharma, Yasmin Sultana. Nanostructured lipid carrier to overcome stratum corneum barrier for the delivery of agomelatine in rat brain; formula optimization, characterization and brain distribution study.
International journal of pharmaceutics.
2021 Sep; 607(?):121006. doi:
10.1016/j.ijpharm.2021.121006. [PMID: 34391848] - Vanessa Barbosa Veronesi, Mariana Rodrigues Pioli, Dailson Nogueira de Souza, Caio Jordão Teixeira, Gilson Masahiro Murata, Junia Carolina Santos-Silva, Fernanda Ballerini Hecht, Julia Modesto Vicente, Silvana Bordin, Gabriel Forato Anhê. Agomelatine reduces circulating triacylglycerides and hepatic steatosis in fructose-treated rats.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
2021 Sep; 141(?):111807. doi:
10.1016/j.biopha.2021.111807. [PMID: 34120066] - Rada Cherngwelling, Nattavadee Pengrattanachot, Myat Theingi Swe, Laongdao Thongnak, Sasivimon Promsan, Nichakorn Phengpol, Prempree Sutthasupha, Anusorn Lungkaphin. Agomelatine protects against obesity-induced renal injury by inhibiting endoplasmic reticulum stress/apoptosis pathway in rats.
Toxicology and applied pharmacology.
2021 08; 425(?):115601. doi:
10.1016/j.taap.2021.115601. [PMID: 34081941] - Ayman M Mahmoud, Omnia A M Abd El-Ghafar, Mohammed A Alzoghaibi, Emad H M Hassanein. Agomelatine prevents gentamicin nephrotoxicity by attenuating oxidative stress and TLR-4 signaling, and upregulating PPARγ and SIRT1.
Life sciences.
2021 Aug; 278(?):119600. doi:
10.1016/j.lfs.2021.119600. [PMID: 33984362] - Fengpei Chen, Shijia Chen, Jie Liu, Nashwa Amin, Weidong Jin, Marong Fang. Agomelatine Softens Depressive-Like Behavior through the Regulation of Autophagy and Apoptosis.
BioMed research international.
2021; 2021(?):6664591. doi:
10.1155/2021/6664591. [PMID: 33791372] - Hanaa M Khalaf, Ahlam M Abdalla, Amira F Ahmed, Asmaa Mohamed Abdel-Aziz. Role of nitric oxide in mediating the cardioprotective effect of agomelatine against isoproterenol-induced myocardial injury in rats.
Naunyn-Schmiedeberg's archives of pharmacology.
2020 10; 393(10):1809-1823. doi:
10.1007/s00210-020-01860-y. [PMID: 32399613] - N A Uvais. Psychological Impact of the COVID-19 Pandemic Among the Elderly: A Case Series From India.
The primary care companion for CNS disorders.
2020 06; 22(4):. doi:
10.4088/pcc.20com02675. [PMID: 32589829] - Hagit Cohen, Joseph Zohar, Lior Carmi. Effects of agomelatine on behaviour, circadian expression of period 1 and period 2 clock genes and neuroplastic markers in the predator scent stress rat model of PTSD.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
2020 04; 21(4):255-273. doi:
10.1080/15622975.2018.1523560. [PMID: 30230406] - Mai Ahmed Tawfik, Mina Ibrahim Tadros, Magdy Ibrahim Mohamed, Sara Nageeb El-Helaly. Low-Frequency versus High-Frequency Ultrasound-Mediated Transdermal Delivery of Agomelatine-Loaded Invasomes: Development, Optimization and in-vivo Pharmacokinetic Assessment.
International journal of nanomedicine.
2020; 15(?):8893-8910. doi:
10.2147/ijn.s283911. [PMID: 33209023] - Shakeeb Ahmed, Azka Gull, Mohd Aqil, Mohd Danish Ansari, Yasmin Sultana. Poloxamer-407 thickened lipid colloidal system of agomelatine for brain targeting: Characterization, brain pharmacokinetic study and behavioral study on Wistar rats.
Colloids and surfaces. B, Biointerfaces.
2019 Sep; 181(?):426-436. doi:
10.1016/j.colsurfb.2019.05.016. [PMID: 31176115] - Brian H Harvey, Wilmie Regenass, Walter Dreyer, Marisa Möller. Social isolation rearing-induced anxiety and response to agomelatine in male and female rats: Role of corticosterone, oxytocin, and vasopressin.
Journal of psychopharmacology (Oxford, England).
2019 05; 33(5):640-646. doi:
10.1177/0269881119826783. [PMID: 30789294] - Feifan Xie, An Vermeulen, Pieter Colin, Zeneng Cheng. A semiphysiological population pharmacokinetic model of agomelatine and its metabolites in Chinese healthy volunteers.
British journal of clinical pharmacology.
2019 05; 85(5):1003-1014. doi:
10.1111/bcp.13902. [PMID: 30761579] - Benjamin Stauch, Linda C Johansson, John D McCorvy, Nilkanth Patel, Gye Won Han, Xi-Ping Huang, Cornelius Gati, Alexander Batyuk, Samuel T Slocum, Andrii Ishchenko, Wolfgang Brehm, Thomas A White, Nairie Michaelian, Caleb Madsen, Lan Zhu, Thomas D Grant, Jessica M Grandner, Anna Shiriaeva, Reid H J Olsen, Alexandra R Tribo, Saïd Yous, Raymond C Stevens, Uwe Weierstall, Vsevolod Katritch, Bryan L Roth, Wei Liu, Vadim Cherezov. Structural basis of ligand recognition at the human MT1 melatonin receptor.
Nature.
2019 05; 569(7755):284-288. doi:
10.1038/s41586-019-1141-3. [PMID: 31019306] - Krishna A Lad, Anurag Maheshwari, Bhagawati Saxena. Repositioning of an anti-depressant drug, agomelatine as therapy for brain injury induced by craniotomy.
Drug discoveries & therapeutics.
2019; 13(4):189-197. doi:
10.5582/ddt.2019.01056. [PMID: 31534070] - H Aygun, S S Gul. Protective effect of melatonin and agomelatine on adriamycin-induced nephrotoxicity in rat model: a renal scintigraphy and biochemical study.
Bratislavske lekarske listy.
2019 ; 120(2):113-118. doi:
10.4149/bll_2019_018. [PMID: 30793614] - H Aygun, S S Gul. Cardioprotective effect of melatonin and agomelatine on doxorubicin-induced cardiotoxicity in a rat model: an electrocardiographic, scintigraphic and biochemical study.
Bratislavske lekarske listy.
2019; 120(4):249-255. doi:
10.4149/bll_2019_045. [PMID: 31023046] - Hongjuan Zhang, Chenguang Pu, Qiao Wang, Xinyi Tan, Jingxin Gou, Haibing He, Yu Zhang, Tian Yin, Yanjiao Wang, Xing Tang. Physicochemical Characterization and Pharmacokinetics of Agomelatine-Loaded PLGA Microspheres for Intramuscular Injection.
Pharmaceutical research.
2018 Nov; 36(1):9. doi:
10.1007/s11095-018-2538-7. [PMID: 30411255] - Mayada Said, Ibrahim Elsayed, Ahmed A Aboelwafa, Ahmed H Elshafeey. A novel concept of overcoming the skin barrier using augmented liquid nanocrystals: Box-Behnken optimization, ex vivo and in vivo evaluation.
Colloids and surfaces. B, Biointerfaces.
2018 Oct; 170(?):258-265. doi:
10.1016/j.colsurfb.2018.06.025. [PMID: 29935419] - Tong-Hua Yang, Yun-Bao Ma, Chang-An Geng, De-Xiu Yan, Xiao-Yan Huang, Tian-Ze Li, Xue-Mei Zhang, Ji-Jun Chen. Synthesis and biological evaluation of magnolol derivatives as melatonergic receptor agonists with potential use in depression.
European journal of medicinal chemistry.
2018 Aug; 156(?):381-393. doi:
10.1016/j.ejmech.2018.07.027. [PMID: 30015074] - Jana Tchekalarova, Tzveta Stoynova, Kalina Ilieva, Rumyana Mitreva, Milena Atanasova. Agomelatine treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light.
Pharmacology, biochemistry, and behavior.
2018 08; 171(?):1-9. doi:
10.1016/j.pbb.2018.05.016. [PMID: 29807067] - Jana Tchekalarova, Dimitrinka Atanasova, Lidia Kortenska, Milena Atanasova, Nikolai Lazarov. Chronic agomelatine treatment prevents comorbid depression in the post-status epilepticus model of acquired epilepsy through suppression of inflammatory signaling.
Neurobiology of disease.
2018 07; 115(?):127-144. doi:
10.1016/j.nbd.2018.04.005. [PMID: 29653194] - Maha M Abdelrahman, Ibrahim A Naguib, Mohamed R El Ghobashy, Nesma A Ali. Stability-Indicating HPLC and HPTLC Methods for Determination of Agomelatine and its Degradation Products.
Journal of chromatographic science.
2018 Apr; 56(4):317-326. doi:
10.1093/chromsci/bmx114. [PMID: 29342234] - Wilmie Regenass, Marisa Möller, Brian H Harvey. Studies into the anxiolytic actions of agomelatine in social isolation reared rats: Role of corticosterone and sex.
Journal of psychopharmacology (Oxford, England).
2018 02; 32(2):134-145. doi:
10.1177/0269881117735769. [PMID: 29082818] - Jagruti B Prajapati, Sneha D Verma, Amit A Patel. Oral bioavailability enhancement of agomelatine by loading into nanostructured lipid carriers: Peyer's patch targeting approach.
International journal of nanomedicine.
2018; 13(T-NANO 2014 Abstracts):35-38. doi:
10.2147/ijn.s124703. [PMID: 29593392] - Keshav Gupta, Rachna Gupta, M S Bhatia, A K Tripathi, Lalit K Gupta. Effect of Agomelatine and Fluoxetine on HAM-D Score, Serum Brain-Derived Neurotrophic Factor, and Tumor Necrosis Factor-α Level in Patients With Major Depressive Disorder With Severe Depression.
Journal of clinical pharmacology.
2017 Dec; 57(12):1519-1526. doi:
10.1002/jcph.963. [PMID: 28833192] - Ahmed M Fatouh, Ahmed H Elshafeey, Ahmed Abdelbary. Agomelatine-based in situ gels for brain targeting via the nasal route: statistical optimization, in vitro, and in vivo evaluation.
Drug delivery.
2017 Nov; 24(1):1077-1085. doi:
10.1080/10717544.2017.1357148. [PMID: 28745530] - You-Lin Tain, Yu-Ju Lin, Julie Y H Chan, Chien-Te Lee, Chien-Ning Hsu. Maternal melatonin or agomelatine therapy prevents programmed hypertension in male offspring of mother exposed to continuous light.
Biology of reproduction.
2017 Oct; 97(4):636-643. doi:
10.1093/biolre/iox115. [PMID: 29025027] - M Suhaib Azim, Nidhi B Agarwal, Divya Vohora. Effects of agomelatine on pentylenetetrazole-induced kindling, kindling-associated oxidative stress, and behavioral despair in mice and modulation of its actions by luzindole and 1-(m-chlorophenyl) piperazine.
Epilepsy & behavior : E&B.
2017 07; 72(?):140-144. doi:
10.1016/j.yebeh.2017.03.019. [PMID: 28578215] - Cuiyun Li, Jing Xu, Yan Zheng, Guiling Chen, Jianmeng Wang, Liying Ma, Yan Qiao, Junqi Niu, Min Wu, Hong Zhang, Xiaojiiao Li, Hong Chen, Xiaoxue Zhu, Chengjiao Liu, Yanhua Ding. Bioequivalence and Pharmacokinetic Profiles of Agomelatine 25-mg Tablets in Healthy Chinese Subjects: A Four-Way Replicate Crossover Study Demonstrating High Intra- and Inter-Individual Variations.
Chemical & pharmaceutical bulletin.
2017 Jun; 65(6):524-529. doi:
10.1248/cpb.c16-00866. [PMID: 28392509] - Gurkan Yigitturk, Ahmet Cagdas Acara, Oytun Erbas, Fatih Oltulu, Nefise Ulku Karabay Yavasoglu, Aysegul Uysal, Altug Yavasoglu. The antioxidant role of agomelatine and gallic acid on oxidative stress in STZ induced type I diabetic rat testes.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
2017 Mar; 87(?):240-246. doi:
10.1016/j.biopha.2016.12.102. [PMID: 28061407] - Ahmed M Fatouh, Ahmed H Elshafeey, Ahmed Abdelbary. Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics.
Drug design, development and therapy.
2017; 11(?):1815-1825. doi:
10.2147/dddt.s102500. [PMID: 28684900] - Sarawut Lapmanee, Jantarima Charoenphandhu, Jarinthorn Teerapornpuntakit, Nateetip Krishnamra, Narattaphol Charoenphandhu. Agomelatine, venlafaxine, and running exercise effectively prevent anxiety- and depression-like behaviors and memory impairment in restraint stressed rats.
PloS one.
2017; 12(11):e0187671. doi:
10.1371/journal.pone.0187671. [PMID: 29099859] - N Akaras, T Bal, H Atilay, J Selli, M B Halici. Protective effects of agomelatine on testicular damage caused by bortezomib.
Biotechnic & histochemistry : official publication of the Biological Stain Commission.
2017; 92(8):552-559. doi:
10.1080/10520295.2017.1350748. [PMID: 29161153] - Arif Demirdaş, Mustafa Nazıroğlu, Gülin Özdamar Ünal. Agomelatine reduces brain, kidney and liver oxidative stress but increases plasma cytokine production in the rats with chronic mild stress-induced depression.
Metabolic brain disease.
2016 12; 31(6):1445-1453. doi:
10.1007/s11011-016-9874-2. [PMID: 27438049] - Jaya Thomas, R Khanam, Divya Vohora. Augmentation of antidepressant effects of venlafaxine by agomelatine in mice are independent of kynurenine pathway.
Neurochemistry international.
2016 10; 99(?):103-109. doi:
10.1016/j.neuint.2016.06.008. [PMID: 27311540] - Gabriel Perlemuter, Patrice Cacoub, Dominique Valla, Dominique Guyader, Barbara Saba, Cécile Batailler, Kevin Moore. Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients.
CNS drugs.
2016 09; 30(9):877-88. doi:
10.1007/s40263-016-0351-6. [PMID: 27342740] - Xing Liu, Yuan-Fu Lu, Xinfu Guan, Mingkun Zhao, Jin Wang, Feng Li. Characterizing novel metabolic pathways of melatonin receptor agonist agomelatine using metabolomic approaches.
Biochemical pharmacology.
2016 06; 109(?):70-82. doi:
10.1016/j.bcp.2016.03.020. [PMID: 27021842] - Giovanni Martinotti, Mauro Pettorruso, Domenico De Berardis, Paola Annunziata Varasano, Gabriella Lucidi Pressanti, Valeria De Remigis, Alessandro Valchera, Valerio Ricci, Marco Di Nicola, Luigi Janiri, Giovanni Biggio, Massimo Di Giannantonio. Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms.
The international journal of neuropsychopharmacology.
2016 05; 19(5):. doi:
10.1093/ijnp/pyw003. [PMID: 26775293] - Atakan Yucel, Nermin Yucel, Seckin Ozkanlar, Elif Polat, Adem Kara, Halil Ozcan, Mustafa Gulec. Effect of agomelatine on adult hippocampus apoptosis and neurogenesis using the stress model of rats.
Acta histochemica.
2016 Apr; 118(3):299-304. doi:
10.1016/j.acthis.2016.02.007. [PMID: 26970810] - Aline Haas de Mello, Luana da Rosa Souza, Ana Carla Moreira Cereja, Rosiane de Bona Schraiber, Drielly Florentino, Maryane Modolon Martins, Fabricia Petronilho, João Quevedo, Gislaine Tezza Rezin. Effect of subchronic administration of agomelatine on brain energy metabolism and oxidative stress parameters in rats.
Psychiatry and clinical neurosciences.
2016 Apr; 70(4):159-66. doi:
10.1111/pcn.12371. [PMID: 26548699] - Nurşah Başol, Oytun Erbaş, Türker Çavuşoğlu, Ayfer Meral, Utku Ateş. Beneficial effects of agomelatine in experimental model of sepsis-related acute kidney injury.
Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES.
2016 Mar; 22(2):121-6. doi:
10.5505/tjtes.2015.29499. [PMID: 27193977] - Ewa Poleszak, Aleksandra Szopa, Elżbieta Wyska, Wirginia Kukuła-Koch, Anna Serefko, Sylwia Wośko, Karolina Bogatko, Andrzej Wróbel, Piotr Wlaź. Caffeine augments the antidepressant-like activity of mianserin and agomelatine in forced swim and tail suspension tests in mice.
Pharmacological reports : PR.
2016 Feb; 68(1):56-61. doi:
10.1016/j.pharep.2015.06.138. [PMID: 26721352] - Adem Karaman, Busra Diyarbakir, Irmak Durur-Subasi, Duygu Kose, Asli Özbek-Bilgin, Atilla Topcu, Cemal Gundogdu, Afak Durur-Karakaya, Zafer Bayraktutan, Fatih Alper. A novel approach to contrast-induced nephrotoxicity: the melatonergic agent agomelatine.
The British journal of radiology.
2016; 89(1061):20150716. doi:
10.1259/bjr.20150716. [PMID: 26886874] - Sema Inanir, Umit Sertan Copoglu, Hanifi Kokacya, Recep Dokuyucu, Oytun Erbas, Ahmet Inanir. Agomelatine Protection in an LPS-Induced Psychosis-Relevant Behavior Model.
Medical science monitor : international medical journal of experimental and clinical research.
2015 Dec; 21(?):3834-9. doi:
10.12659/msm.895505. [PMID: 26647355] - Meizhen Li, Fang Tang, Feifan Xie, Yisha Lv, Peng Yu, Zhi Liu, Zeneng Cheng. Development and validation a LC-MS/MS method for the simultaneous determination of agomelatine and its metabolites, 7-desmethyl-agomelatine and 3-hydroxy-agomelatine in human plasma: Application to a bioequivalence study.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2015 Oct; 1003(?):60-6. doi:
10.1016/j.jchromb.2015.09.018. [PMID: 26409931] - X-l Wang, A-h Du, D Zhang, L-j Meng, M Liu, L-n Zhang, H-n Zhao, H-c Liu. Inter- and Intra-individual Variability in the Pharmacokinetics of Agomelatine Tablets in Chinese Healthy Male Subjects.
Drug research.
2015 Oct; 65(10):552-4. doi:
10.1055/s-0034-1394436. [PMID: 25383559] - Prabhat Singh, Surbhi Gupta, Bhupesh Sharma. Melatonin receptor and KATP channel modulation in experimental vascular dementia.
Physiology & behavior.
2015 Apr; 142(?):66-78. doi:
10.1016/j.physbeh.2015.02.009. [PMID: 25659733] - R N El-Shaheny. Evaluation of agomelatine stability under different stress conditions using an HPLC method with fluorescence detection: application to the analysis of tablets and human plasma.
Luminescence : the journal of biological and chemical luminescence.
2014 Nov; 29(7):920-8. doi:
10.1002/bio.2642. [PMID: 24639056] - Yves Donazzolo, Mathilde Latreille, Marie-Anne Caillaud, Elisabeth Mocaer, Laure Seguin. Evaluation of the effects of therapeutic and supratherapeutic doses of agomelatine on the QT/QTc interval: a phase I, randomized, double-blind, placebo-controlled and positive-controlled, crossover thorough QT/QTc study conducted in healthy volunteers.
Journal of cardiovascular pharmacology.
2014 Nov; 64(5):440-51. doi:
10.1097/fjc.0000000000000136. [PMID: 24977347] - Sema Koyuturk, Nafiz Oncu Can, Zeki Atkosar, Goksel Arli. A novel dilute and shoot HPLC assay method for quantification of irbesartan and hydrochlorothiazide in combination tablets and urine using second generation C18-bonded monolithic silica column with double gradient elution.
Journal of pharmaceutical and biomedical analysis.
2014 Aug; 97(?):103-10. doi:
10.1016/j.jpba.2014.04.026. [PMID: 24876066] - Maria Addolorata Saracino, Laura Mercolini, Giorgia Carbini, Vittorio Volterra, Antonio Lucio Quarta, Mario Amore, Maria Augusta Raggi. Multi-matrix assay of the first melatonergic antidepressant agomelatine by combined liquid chromatography-fluorimetric detection and microextraction by packed sorbent.
Journal of pharmaceutical and biomedical analysis.
2014 Jul; 95(?):61-7. doi:
10.1016/j.jpba.2014.02.005. [PMID: 24631958] - Surbhi Gupta, Bhupesh Sharma. Pharmacological benefits of agomelatine and vanillin in experimental model of Huntington's disease.
Pharmacology, biochemistry, and behavior.
2014 Jul; 122(?):122-35. doi:
10.1016/j.pbb.2014.03.022. [PMID: 24704436] - Abdullah Akpinar, Abdülhadi Cihangir Uğuz, Mustafa Nazıroğlu. Agomelatine and duloxetine synergistically modulates apoptotic pathway by inhibiting oxidative stress triggered intracellular calcium entry in neuronal PC12 cells: role of TRPM2 and voltage-gated calcium channels.
The Journal of membrane biology.
2014 May; 247(5):451-9. doi:
10.1007/s00232-014-9652-1. [PMID: 24682240] - Ying Chang, Weiyi Pi, Wei Ang, Yuanyuan Liu, Chunlong Li, Jiajia Zheng, Li Xiong, Tao Yang, Youfu Luo. Synthesis and evaluation of amide side-chain modified Agomelatine analogues as potential antidepressant-like agents.
Bioorganic & medicinal chemistry letters.
2014 Apr; 24(7):1672-6. doi:
10.1016/j.bmcl.2014.02.065. [PMID: 24631187] - L Song, Q Du, X Jiang, L Wang. Effect of CYP1A2 polymorphism on the pharmacokinetics of agomelatine in Chinese healthy male volunteers.
Journal of clinical pharmacy and therapeutics.
2014 Apr; 39(2):204-9. doi:
10.1111/jcpt.12118. [PMID: 24372004] - Barthel Schmelting, Silke Corbach-Söhle, Susan Kohlhause, Christina Schlumbohm, Gabriele Flügge, Eberhard Fuchs. Agomelatine in the tree shrew model of depression: effects on stress-induced nocturnal hyperthermia and hormonal status.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.
2014 Mar; 24(3):437-47. doi:
10.1016/j.euroneuro.2013.07.010. [PMID: 23978391] - Xiaolin Wang, Dan Zhang, Man Liu, Hongna Zhao, Aihua Du, Lingjie Meng, Huichen Liu. LC-MS/MS method for the determination of agomelatine in human plasma and its application to a pharmacokinetic study.
Biomedical chromatography : BMC.
2014 Feb; 28(2):218-22. doi:
10.1002/bmc.3008. [PMID: 23918681] - M V Gorbenko, T N Popova, K K Shul'gin, S S Popov. [The activity of glutathione antioxidant system at melaksen and valdoxan action under experimental hyperthyroidism in rats].
Biomeditsinskaia khimiia.
2013 Sep; 59(5):541-9. doi:
10.18097/pbmc20135905541. [PMID: 24479344] - Carlos Clayton Torres Aguiar, Anália Barbosa Almeida, Paulo Victor Pontes Araújo, Germana Silva Vasconcelos, Edna Maria Camelo Chaves, Otoni Cardoso do Vale, Danielle Silveira Macêdo, Luzia Kalyne Almeida Moreira Leal, Glauce Socorro de Barros Viana, Silvânia Maria Mendes Vasconcelos. Effects of agomelatine on oxidative stress in the brain of mice after chemically induced seizures.
Cellular and molecular neurobiology.
2013 Aug; 33(6):825-35. doi:
10.1007/s10571-013-9949-0. [PMID: 23801192] - D Karaiskos, E Tzavellas, I Ilias, I Liappas, T Paparrigopoulos. Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus.
International journal of clinical practice.
2013 Mar; 67(3):257-60. doi:
10.1111/ijcp.12112. [PMID: 23409693] - Edoardo Spina, Gianluca Trifirò, Filippo Caraci. Clinically significant drug interactions with newer antidepressants.
CNS drugs.
2012 Jan; 26(1):39-67. doi:
10.2165/11594710-000000000-00000. [PMID: 22171584] - George Anderson, Michael Maes, Michael Berk. Inflammation-related disorders in the tryptophan catabolite pathway in depression and somatization.
Advances in protein chemistry and structural biology.
2012; 88(?):27-48. doi:
10.1016/b978-0-12-398314-5.00002-7. [PMID: 22814705] - Marco Antonioli, Joanna Rybka, Livia A Carvalho. Neuroimmune endocrine effects of antidepressants.
Neuropsychiatric disease and treatment.
2012; 8(?):65-83. doi:
10.2147/ndt.s16409. [PMID: 22347798] - Satish R Patil, Ketan K Nerurkar, Ashok M Kalamkar, Vishwas Pukale, Kiran V Mangaonkar, Satish G Pingale. Validated LC-MS/MS method for quantification of agomelatine in human plasma and its application in a pharmacokinetic study.
Journal of mass spectrometry : JMS.
2012 Jan; 47(1):23-8. doi:
10.1002/jms.2020. [PMID: 22282085] - Venkatramanujam Srinivasan, Charanjit Kaur, Seithikurippu Pandi-Perumal, Gregory M Brown, Daniel P Cardinali. Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value.
International journal of Alzheimer's disease.
2010 Dec; 2011(?):741974. doi:
10.4061/2011/741974. [PMID: 21197086] - Shrinivas K Kulkarni, Ashish Dhir. Current investigational drugs for major depression.
Expert opinion on investigational drugs.
2009 Jun; 18(6):767-88. doi:
10.1517/13543780902880850. [PMID: 19426122] - Gillian W Reierson, Claudio A Mastronardi, Julio Licinio, Ma-Li Wong. Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent.
Clinical pharmacology : advances and applications.
2009; 1(?):1-6. doi:
10.2147/cpaa.s7157. [PMID: 22291481] - Byong-Su Jang, Hyeran Kim, Shinn-Won Lim, Ki-Won Jang, Doh-Kwan Kim. Serum S100B Levels and Major Depressive Disorder: Its Characteristics and Role in Antidepressant Response.
Psychiatry investigation.
2008 Sep; 5(3):193-8. doi:
10.4306/pi.2008.5.3.193. [PMID: 20046365] - Seithikurippu R Pandi-Perumal, Venkatramanujan Srinivasan, D Warren Spence, Daniel P Cardinali. Role of the melatonin system in the control of sleep: therapeutic implications.
CNS drugs.
2007; 21(12):995-1018. doi:
10.2165/00023210-200721120-00004. [PMID: 18020480] - Alfred J Lewy, Jennifer N Rough, Jeannine B Songer, Neelam Mishra, Krista Yuhas, Jonathan S Emens. The phase shift hypothesis for the circadian component of winter depression.
Dialogues in clinical neuroscience.
2007; 9(3):291-300. doi:
NULL. [PMID: 17969866] - S R Pandi-Perumal, V Srinivasan, G J M Maestroni, D P Cardinali, B Poeggeler, R Hardeland. Melatonin: Nature's most versatile biological signal?.
The FEBS journal.
2006 Jul; 273(13):2813-38. doi:
10.1111/j.1742-4658.2006.05322.x. [PMID: 16817850] - Rachel Leproult, Anne Van Onderbergen, Mireille L'hermite-Balériaux, Eve Van Cauter, Georges Copinschi. Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men.
Clinical endocrinology.
2005 Sep; 63(3):298-304. doi:
10.1111/j.1365-2265.2005.02341.x. [PMID: 16117817] - J J Bogaards, E M Hissink, M Briggs, R Weaver, R Jochemsen, P Jackson, M Bertrand, P J van Bladeren. Prediction of interindividual variation in drug plasma levels in vivo from individual enzyme kinetic data and physiologically based pharmacokinetic modeling.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
2000 Dec; 12(2):117-24. doi:
10.1016/s0928-0987(00)00146-9. [PMID: 11102739] - Y S Chu, K R Shieh, Z F Yuan, J T Pan. Stimulatory and entraining effect of melatonin on tuberoinfundibular dopaminergic neuron activity and inhibition on prolactin secretion.
Journal of pineal research.
2000 May; 28(4):219-26. doi:
10.1034/j.1600-079x.2000.280404.x. [PMID: 10831157] - S Conway, S J Canning, H E Howell, E S Mowat, P Barrett, J E Drew, P Delagrange, D Lesieur, P J Morgan. Characterisation of human melatonin mt(1) and MT(2) receptors by CRE-luciferase reporter assay.
European journal of pharmacology.
2000 Feb; 390(1-2):15-24. doi:
10.1016/s0014-2999(99)00914-0. [PMID: 10708702] - G Simonin, L Bru, E Lelièvre, J P Jeanniot, N Bromet, B Walther, C Boursier-Neyret. Determination of melatonin in biological fluids in the presence of the melatonin agonist S 20098: comparison of immunological techniques and GC-MS methods.
Journal of pharmaceutical and biomedical analysis.
1999 Nov; 21(3):591-601. doi:
10.1016/s0731-7085(99)00150-8. [PMID: 10701426] - L Martinet, B Guardiola-Lemaitre, E Mocaer. Entrainment of circadian rhythms by S-20098, a melatonin agonist, is dose and plasma concentration dependent.
Pharmacology, biochemistry, and behavior.
1996 Aug; 54(4):713-8. doi:
10.1016/0091-3057(95)02221-x. [PMID: 8853194] - A Le Quellec, S Dupin, A E Tufenkji, P Genissel, G Houin. Microdialysis: an alternative for in vitro and in vivo protein binding studies.
Pharmaceutical research.
1994 Jun; 11(6):835-8. doi:
10.1023/a:1018973607051. [PMID: 7937522]